Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Thrombosis and Thrombolysis
Metadata
Title
A systematic review of ultrasound-accelerated catheter-directed thrombolysis in the treatment of deep vein thrombosis
Publication date
01-04-2018
Published in
Journal of Thrombosis and Thrombolysis / Issue 3/2018
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-018-1629-y

Other articles of this Issue 3/2018

Journal of Thrombosis and Thrombolysis 3/2018 Go to the issue

EditorialNotes

Highlights from the 2017 American Heart Association Scientific Sessions in Anaheim, California

OriginalPaper

Cryptogenic acute limb ischemia: a retrospective cohort study defining a previously undescribed clinical entity

OriginalPaper

Risk of discontinuation of clopidogrel after 1 month following bare-metal stents: a propensity-score adjusted comparison with continued administration of clopidogrel after drug-eluting stents

OriginalPaper

Novel oral anticoagulants in the preoperative period: a meta-analysis

OriginalPaper

Does my patient have a pulmonary embolism? The Wells vs. PISA 2 rule in orthopedic patients

OriginalPaper

Mind the gap: results of a multispecialty survey on coordination of care for peri-procedural anticoagulation

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits